Pre-habilitation of Patients With Head and Neck Cancer (SYNK)
Primary Purpose
Head and Neck Cancer
Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Swallowing therapy & resistance training
Sponsored by
About this trial
This is an interventional supportive care trial for Head and Neck Cancer focused on measuring Head and Neck Cancer, Intervention, Rehabilitation, Late Effects, Dysphagia
Eligibility Criteria
Inclusion Criteria:
- Histological proven cancer in one or more of the following areas: larynx, hypopharynx, oropharynx, cavi oris, or unknown primary tumor
- Set to curative radiotherapy with or without concurrent chemotherapy for treatment of cancer in the head and neck region in accordance with the Danish Head and Neck Cancer Group (DAHANCA) guidelines
- Fully self-reliant
- Danish skills, oral and written
- Informed consent
Exclusion Criteria:
- Previously received treatment for head and neck cancer (radiotherapy, chemotherapy and/or surgery).
- Pregnancy
- ECOG performance status > 2
- Presence of psychological-, family-, sociological- or geographical issues that could prevent the patient from completing the intervention
- Simultaneous or previous illness or conditions that could prevent the patient's ability to complete the intervention.
Sites / Locations
- Næstved Sygehus
- Rigshospitalet
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Swallowing therapy & resistance training
Standard Care
Arm Description
Mouth opening and swallowing exercise intervention by occupational therapist for half an hour 3 times a week for 5-6 weeks during radiotherapy. Progressive resistance training by physiotherapist for 1 hour twice weekly for 5-6 weeks during radiotherapy.
Patients in this arm are randomized to usual care / control group
Outcomes
Primary Outcome Measures
Swallowing function measured by penetration aspiration scale (PAS) during a Fiber Endoscopic Evaluation of Swallowing (FEES).
To investigate the change in swallowing function among patients in intervention- and the control group from baseline to 14 and 58 weeks follow up and the difference in change between intervention - and the control group.
Secondary Outcome Measures
Level of fatigue by the EORCT QLQ-C30 3-point fatigue subscale.
To investigate the change in fatigue among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Maximal Interincisal Distance (MID) by Therabite Range of Motion (ROM) scale
To investigate the change in mouth opening and the development of trismus (defined as MID ≤ 35mm) among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Dysphagia related quality of life by M.D. Anderson Dysphagia Inventory (MDADI)
To investigate the change in patient reported quality of life related to dysphagia among patients in intervention- and the control group from baseline to 6, 14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group. We will also use this outcome to evaluate correlation or deviations in patient vs observer rated outcomes by comparing the MDADI to the PAS score (primary outcome).
Health related quality of Life by the European Organisation for Research and Treatment of Cancer (EORCT) Quality if Life Questionnaire (QLQ)-30 and EORCT QLQ - H&N35
To investigate the change in health related quality of life among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Level of oral intake by Functional Oral Intake Scale (FOIS)
To investigate the change in oral intake and tube dependency among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Weight loss by body weight
To investigate the change in weight loss among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Physical strength by 30 seconds Sit to Stand (STS) test.
To investigate the change in lower extremities' strength as an expression of the overall physical strength among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Pain by numerical rating scale (NRS)
To investigate the change in pain among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Depression by Major Depression Inventory (MDI)
To investigate the change in depressive symptoms among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Anxiety by Symptom Check List (SCL-92) Anxiety subscale
To investigate the change in anxiety among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Performance Status by Eastern Cooperative Oncology Group (ECOG) performance scale
To investigate the change in performance status among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Subjective symptoms of dysphagia by Eating Assessment Tool (EAT-10)
EAT-10 is a questionnaire screening tool used to evaluate patient-experienced symptoms of dysphagia and measures the level of ten specific difficulties related to swallowing. We will measure this outcome at the same time as our primary outcome to analyze the correlation between the subjective and objective measures of oropharyngeal dysphagia.
Full Information
NCT ID
NCT02385929
First Posted
February 9, 2015
Last Updated
March 25, 2020
Sponsor
Irene Wessel
Collaborators
Danish Cancer Society, Danish Association of Occupational Therapist, Rigshospitalet, Denmark, Danish Cancer Research Foundation
1. Study Identification
Unique Protocol Identification Number
NCT02385929
Brief Title
Pre-habilitation of Patients With Head and Neck Cancer
Acronym
SYNK
Official Title
Bimodal Pre-habilitation Program to Improve Symptom Control After Treatment for Head and Neck Cancer
Study Type
Interventional
2. Study Status
Record Verification Date
March 2020
Overall Recruitment Status
Completed
Study Start Date
May 11, 2015 (Actual)
Primary Completion Date
November 2019 (Actual)
Study Completion Date
November 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Irene Wessel
Collaborators
Danish Cancer Society, Danish Association of Occupational Therapist, Rigshospitalet, Denmark, Danish Cancer Research Foundation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to explore whether early initiated physical exercise concurrent with a swallowing and mouth opening exercise program will have a positive effect on swallowing function and other quality of life aspects in patients treated with radiotherapy for head and neck cancer. The investigators hypothesize that patients who complete the program will have improved swallowing function and physical function one year after completing their treatment compared to patients who do not participate in the training program.
Detailed Description
Although the potential negative impact of head and neck cancer (HNC) and its treatment on eating ability and quality of life is well documented there is no evidence based and standardized rehabilitation program available for Danish patients affected by HNC while going through radiotherapy (with or without concurrent chemotherapy). This study proposal is based on a thorough literature review on HNC treatment and late effects, and interventions targeting dysphagia and physical functioning.
Traditionally, rehabilitation is initiated when loss of function is already established. Emerging evidence suggests, however, that it can be of benefit to the patient to initiate an early rehabilitation process (prehabilitation) starting before initiation of treatment and during treatment. Prehabilitation aims to enhance pre-treatment functional capacity for better tolerance of treatment, facilitate general recovery, and prevent development of functional impairment or reduce the extent of these problems in a long-term perspective. HNC patients have a unique set of functional challenges such as pre- and post-treatment dysphagia, pain, and weight loss and often also high baseline levels of alcohol and tobacco consumption. In addition, studies have shown that only 31 % and 9 % of HNC patients are meeting public health guidelines for physical activity before and after diagnosis, respectively, and that weight loss in HNC patients treated with chemoradiation begin after only 1 week of therapy. Most of the weight loss was lean body mass (LBM) rather than fat loss. Loss of LBM is significantly associated with physical performance and increased functional dependence. The level of physical activity typically decreases significantly during treatment.
Dysphagia is considered the most prominent complication to HNC and its treatment, affecting physical function and quality of life. Post treatment dysphagia occurs in a significant proportion of patients and results from multiple factors such as xerostomia, taste loss, decreased sensory function, fibrosis and trismus. Disuse of swallowing muscles due to acute radiation effects or tube feeding can contribute to decline in swallowing function. Often, difficulties in swallowing and mouth opening are presenting features of HNC even at the time of diagnosis. To reduce these problems, patients may do a series of exercises before and during treatment to promote strength, mobility, and endurance of base of tongue, pharyngeal constrictors, and suprahyoid strap muscles. Although no definitive trials have yet been carried out, small randomized controlled trials (RCTs) and observational studies investigating pre-treatment swallowing and/or mouth opening exercise programs show promising benefits. Further, the few studies of resistance and cardio training on functional capacity in HNC patients are generally promising with medium to large effects on fatigue and physical function measures. For weight loss it seems as if progressive resistance training (PRT) is able to almost reverse the loss of LBM in HNC patients.
Generally studies on swallowing therapy for HNC patients have relied greatly on self-practice, and thus report low compliance. In view of this knowledge the investigators determine that there is a need for studies that include patients with HNC undergoing (chemo)radiation therapy focusing on i) prevention of dysphagia and loss of muscle strength and ii) improvement of compliance to mouth opening and swallowing exercises.
The purpose of the SYNK study is a randomized design to test the effect of theory based intervention on eating dysfunctions secondary to radiation treatment for HNC. The SYNK intervention consists of: i) individual instructions in swallowing and mouth opening exercises 3 days per week by occupational therapist throughout radiotherapy, ii) progressive resistance training twice weekly by physiotherapist, either individually or group based, throughout radiotherapy, iii) daily home-based swallowing and mouth opening exercises from beginning of treatment until 2 months after end-of-treatment (self-practice), and iv) weekly follow-up phone contacts with occupational therapists from end-of-treatment and 2 months onwards.
The investigators will enroll patients from the Oncological Department Rigshospitalet and randomize 240 patients. Patients will be randomized (1:1) to standard care plus the SYNK intervention and to standard care (control group).
The proposed study has the potential to support the general health status of HNC patients as well as to minimize adverse late effects of treatment (i.e. swallowing and mouth opening difficulties, general physical deterioration due to physical inactivity and problems with eating, and reduced QoL). The design of the intervention, being early, intensive and bimodal adds a new dimension to research in the prevention of devastating late effects in this particularly vulnerable patient group.
The investigators hypothesize that the SYNK intervention will:
Improve swallowing function
Improve physical function to stop the loss of muscle strength
Improve quality of life and lessen the symptoms of anxiety and depression
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Head and Neck Cancer
Keywords
Head and Neck Cancer, Intervention, Rehabilitation, Late Effects, Dysphagia
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
240 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Swallowing therapy & resistance training
Arm Type
Experimental
Arm Description
Mouth opening and swallowing exercise intervention by occupational therapist for half an hour 3 times a week for 5-6 weeks during radiotherapy.
Progressive resistance training by physiotherapist for 1 hour twice weekly for 5-6 weeks during radiotherapy.
Arm Title
Standard Care
Arm Type
No Intervention
Arm Description
Patients in this arm are randomized to usual care / control group
Intervention Type
Behavioral
Intervention Name(s)
Swallowing therapy & resistance training
Intervention Description
i) Individual instructions in swallowing and mouth opening exercises 3 days per week by occupational therapist throughout radiotherapy, ii) Progressive resistance training twice weekly by physiotherapist, either individually or group based, throughout radiotherapy, iii) Daily home-based swallowing and mouth opening exercises from beginning of treatment until 2 months after end-of-treatment.
iv) Weekly follow-up phone contacts with occupational therapists from end-of-treatment and 2 months onwards.
Primary Outcome Measure Information:
Title
Swallowing function measured by penetration aspiration scale (PAS) during a Fiber Endoscopic Evaluation of Swallowing (FEES).
Description
To investigate the change in swallowing function among patients in intervention- and the control group from baseline to 14 and 58 weeks follow up and the difference in change between intervention - and the control group.
Time Frame
Baseline, 14 weeks and 58 weeks. Participants will be followed up till 12 months after they finalize their radiotherapy, an expected average of 58 weeks from baseline.
Secondary Outcome Measure Information:
Title
Level of fatigue by the EORCT QLQ-C30 3-point fatigue subscale.
Description
To investigate the change in fatigue among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Time Frame
baseline, 6 weeks, 14 weeks, 28 weeks and 58 weeks.
Title
Maximal Interincisal Distance (MID) by Therabite Range of Motion (ROM) scale
Description
To investigate the change in mouth opening and the development of trismus (defined as MID ≤ 35mm) among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Time Frame
baseline, 6 weeks, 14 weeks, 28 weeks and 58 weeks.
Title
Dysphagia related quality of life by M.D. Anderson Dysphagia Inventory (MDADI)
Description
To investigate the change in patient reported quality of life related to dysphagia among patients in intervention- and the control group from baseline to 6, 14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group. We will also use this outcome to evaluate correlation or deviations in patient vs observer rated outcomes by comparing the MDADI to the PAS score (primary outcome).
Time Frame
baseline, 6 weeks, 14 weeks, 28 weeks and 58 weeks.
Title
Health related quality of Life by the European Organisation for Research and Treatment of Cancer (EORCT) Quality if Life Questionnaire (QLQ)-30 and EORCT QLQ - H&N35
Description
To investigate the change in health related quality of life among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Time Frame
baseline, 6 weeks, 14 weeks, 28 weeks and 58 weeks.
Title
Level of oral intake by Functional Oral Intake Scale (FOIS)
Description
To investigate the change in oral intake and tube dependency among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Time Frame
baseline, 6 weeks, 14 weeks, 28 weeks and 58 weeks.
Title
Weight loss by body weight
Description
To investigate the change in weight loss among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Time Frame
baseline, 6 weeks, 14 weeks, 28 weeks and 58 weeks.
Title
Physical strength by 30 seconds Sit to Stand (STS) test.
Description
To investigate the change in lower extremities' strength as an expression of the overall physical strength among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Time Frame
baseline, 6 weeks, 14 weeks, 28 weeks and 58 weeks.
Title
Pain by numerical rating scale (NRS)
Description
To investigate the change in pain among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Time Frame
baseline, 6 weeks, 14 weeks, 28 weeks and 58 weeks.
Title
Depression by Major Depression Inventory (MDI)
Description
To investigate the change in depressive symptoms among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Time Frame
baseline, 6 weeks, 14 weeks, 28 weeks and 58 weeks.
Title
Anxiety by Symptom Check List (SCL-92) Anxiety subscale
Description
To investigate the change in anxiety among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Time Frame
baseline, 6 weeks, 14 weeks, 28 weeks and 58 weeks.
Title
Performance Status by Eastern Cooperative Oncology Group (ECOG) performance scale
Description
To investigate the change in performance status among patients in intervention- and the control group from baseline to 6,14, 28 and 58 weeks follow up and the difference in change between intervention - and the control group.
Time Frame
baseline, 6 weeks, 14 weeks, 28 weeks and 58 weeks.
Title
Subjective symptoms of dysphagia by Eating Assessment Tool (EAT-10)
Description
EAT-10 is a questionnaire screening tool used to evaluate patient-experienced symptoms of dysphagia and measures the level of ten specific difficulties related to swallowing. We will measure this outcome at the same time as our primary outcome to analyze the correlation between the subjective and objective measures of oropharyngeal dysphagia.
Time Frame
Participants will be followed up till 12 months after they finalize their radiotherapy, an expected average of 58 weeks from baseline.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Histological proven cancer in one or more of the following areas: larynx, hypopharynx, oropharynx, cavi oris, or unknown primary tumor
Set to curative radiotherapy with or without concurrent chemotherapy for treatment of cancer in the head and neck region in accordance with the Danish Head and Neck Cancer Group (DAHANCA) guidelines
Fully self-reliant
Danish skills, oral and written
Informed consent
Exclusion Criteria:
Previously received treatment for head and neck cancer (radiotherapy, chemotherapy and/or surgery).
Pregnancy
ECOG performance status > 2
Presence of psychological-, family-, sociological- or geographical issues that could prevent the patient from completing the intervention
Simultaneous or previous illness or conditions that could prevent the patient's ability to complete the intervention.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sara F Hajdú, M.Sc
Organizational Affiliation
Rigshospitalet, Denmark
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Susanne O Dalton, professor
Organizational Affiliation
Danish Cancer Society
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Christoffer Johansen, professor
Organizational Affiliation
Rigshospitalet, Denmark
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Irene Wessel, MD, phd
Organizational Affiliation
Rigshospitalet, Denmark
Official's Role
Principal Investigator
Facility Information:
Facility Name
Næstved Sygehus
City
Næstved
State/Province
Region Zealand
ZIP/Postal Code
4700
Country
Denmark
Facility Name
Rigshospitalet
City
Copenhagen
ZIP/Postal Code
2100
Country
Denmark
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
28206871
Citation
Hajdu SF, Wessel I, Johansen C, Kristensen CA, Kadkhoda ZT, Plaschke CC, Dalton SO. Swallowing therapy and progressive resistance training in head and neck cancer patients undergoing radiotherapy treatment: randomized control trial protocol and preliminary data. Acta Oncol. 2017 Feb;56(2):354-359. doi: 10.1080/0284186X.2016.1269193.
Results Reference
background
PubMed Identifier
28271296
Citation
Hajdu SF, Plaschke CC, Johansen C, Dalton SO, Wessel I. Cross-Cultural Translation, Adaptation and Reliability of the Danish M. D. Andeson Dysphagia Inventory (MDADI) in Patients with Head and Neck Cancer. Dysphagia. 2017 Aug;32(4):472-479. doi: 10.1007/s00455-017-9785-3. Epub 2017 Mar 7.
Results Reference
background
PubMed Identifier
26050828
Citation
Fredslund SV, Hogdal N, Christensen MB, Wessel I. Dysphagia training after head and neck cancer fails to follow legislation and national recommendations. Dan Med J. 2015 May;62(5):A5067.
Results Reference
background
PubMed Identifier
30698049
Citation
Hajdu SF, Christensen MB, Kristensen MO, Wessel I, Johansen C, Dalton S. Adherence to preventive swallowing exercises for head and neck cancer patients undergoing (chemo)radiotherapy treatment. Acta Oncol. 2019 May;58(5):658-664. doi: 10.1080/0284186X.2018.1563715. Epub 2019 Jan 30.
Results Reference
derived
Learn more about this trial
Pre-habilitation of Patients With Head and Neck Cancer
We'll reach out to this number within 24 hrs